Notice Type
Departmental
Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Ammonium chloride 25 mg/mL, diphenhydramine hydrochloride 2.5 mg/mL Syrup PSM Holdings Limited, Wiri, Auckland Diphenacough Bisacodyl 10 mg Suppository C B Fleet & Co Inc., Lynchburg, Virginia, United States of America Fleet Laxative Suppositories Metoclopramide hydrochloride 5 mg/mL Injection, solution (syringe and polyamp) Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia Metoclopramide Ketoconazole 2% w/w Shampoo Douglas Pharmaceuticals Limited, Mount Wellington, Auckland Sebizole Basiliximab 20 mg Diluent: Water for injection Injection, powder with diluent Novartis Pharma AG., Basel, Switzerland Diluent: Novartis Pharma AG., Stein, Switzerland Simulect Cefaclor monohydrate 27.8 mg/mL, 55.6 mg/mL equivalent to 25 mg/mL, 50 mg/mL cefaclor anhydrous Suspension, oral Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India Locef Cefaclor monohydrate 267.5 mg/mL, 535 mg equivalent to 250 mg, 500 mg cefaclor anhydrous Capsules, powder filled Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India Locef Dated this 8th day of September 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
Publication Date
17 Sep 1998

Notice Number

1998-go6558

Page Number

3588